Asked by: Alicia Kearns (Conservative - Rutland and Stamford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what contingency plans are in place if the supply of hormone replacement therapy medication is disrupted due to the war in Iran.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department is closely monitoring the Middle East conflict to assess any potential impact on United Kingdom medical supply chains through disruptions to manufacturing and logistics.
We have limited direct exposure to the Middle East for medical products, and we maintain well‑established contingency arrangements to manage medicine and medical device supply disruptions where these occur. These can include coordination of mutual aid, work to identify alternative products, alternative clinical practices, regulatory easements, and/or use of the Express Freight Service which can provide bespoke global logistics services in the event of critical supply disruption.
The Department is not aware of supply issues impacting codeine and co-codamol as a result of the conflict. The Department is aware of supply constraints affecting co-codamol 30 milligram/500 milligram tablets, which pre-date the conflict and which are due to manufacturing issues. These are in limited supply until early July 2026. We have engaged with National Health Service specialist clinicians and issued comprehensive guidance on how to manage patients during this time and advise on available alternative preparations.
Asked by: Alicia Kearns (Conservative - Rutland and Stamford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what contingency plans are in place if the supply of blood pressure medication is disrupted due to the war in Iran.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department is closely monitoring the Middle East conflict to assess any potential impact on United Kingdom medical supply chains through disruptions to manufacturing and logistics.
We have limited direct exposure to the Middle East for medical products, and we maintain well‑established contingency arrangements to manage medicine and medical device supply disruptions where these occur. These can include coordination of mutual aid, work to identify alternative products, alternative clinical practices, regulatory easements, and/or use of the Express Freight Service which can provide bespoke global logistics services in the event of critical supply disruption.
The Department is not aware of supply issues impacting codeine and co-codamol as a result of the conflict. The Department is aware of supply constraints affecting co-codamol 30 milligram/500 milligram tablets, which pre-date the conflict and which are due to manufacturing issues. These are in limited supply until early July 2026. We have engaged with National Health Service specialist clinicians and issued comprehensive guidance on how to manage patients during this time and advise on available alternative preparations.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he is taking steps to increase reserves of helium within the NHS.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department is closely monitoring the impacts of the Middle East conflict on the medical supply chain, including on the supply of helium. We have engaged with industry and received assurance on the stability of continued helium supply through contingency planning and sourcing through multiple global routes. We will continue to monitor the supply of helium and other medical products to mitigate any potential impacts on patient care.
Asked by: Alicia Kearns (Conservative - Rutland and Stamford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what contingency plans are in place if the supply of intravenous bags, syringes and gloves are disrupted due to the war in Iran.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department is closely monitoring the Middle East conflict to assess any potential impact on United Kingdom medical supply chains through disruptions to manufacturing and logistics.
We have limited direct exposure to the Middle East for medical products, and we maintain well‑established contingency arrangements to manage medicine and medical device supply disruptions where these occur. These can include coordination of mutual aid, work to identify alternative products, alternative clinical practices, regulatory easements, and/or use of the Express Freight Service which can provide bespoke global logistics services in the event of critical supply disruption.
The Department is not aware of supply issues impacting codeine and co-codamol as a result of the conflict. The Department is aware of supply constraints affecting co-codamol 30 milligram/500 milligram tablets, which pre-date the conflict and which are due to manufacturing issues. These are in limited supply until early July 2026. We have engaged with National Health Service specialist clinicians and issued comprehensive guidance on how to manage patients during this time and advise on available alternative preparations.
Asked by: Cameron Thomas (Liberal Democrat - Tewkesbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of hospital admissions related to dental infections or complications preventable through earlier oral health education and intervention.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
No estimate is available for the number of hospital admissions related to dental infections or complications preventable through earlier oral health education and intervention. However, official statistics on hospital tooth extractions for children and young adults being admitted to hospital for tooth extractions in the financial year ending 2025 are available at the following link:
https://www.gov.uk/government/statistics/hospital-tooth-extractions-in-0-to-19-year-olds-2025
Asked by: David Davis (Conservative - Goole and Pocklington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what information his Department holds on the (a) advice and (b) approval that was given by NHS England in regard to (i) former CEO Jonathan Lofthouse leaving the Humber Health Partnership, (ii) former chair Sean Lyons leaving the Humber Health Partnership and (iii) the appointment of Lyn Simpson as interim CEO at Humber Health Partnership (Hull University Teaching Hospitals and Northern Lincolnshire and Goole Foundation Trust).
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: David Davis (Conservative - Goole and Pocklington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what action NHS England took following the findings of the review by JMM & Associates – People Matters into leadership issues at the Humber Health Partnership (Hull University Teaching Hospitals and Northern Lincolnshire and Goole Foundation Trust).
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: David Davis (Conservative - Goole and Pocklington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what were the findings of the review by JMM & Associates – People Matters into leadership issues at the Humber Health Partnership (Hull University Teaching Hospitals and Northern Lincolnshire and Goole Foundation Trust).
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Luke Evans (Conservative - Hinckley and Bosworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the answer of 30 March 2026 to WPQ 122758, whether there will be any limitations on what qualifications staff will be required to have in order to triage in the Elective Single Point of Access Model.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: David Davis (Conservative - Goole and Pocklington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, which public body is paying the salary of Jonathan Lofthouse, director of turnaround and recovery for NHS England’s North East and Yorkshire region; and what salary is being paid to Mr Lofthouse.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.